Clinical Research Division, Fred Hutch
Dr. Mary Redman is a biostatistician who specializes in complex studies, such as estimating the effects of treatments or environmental exposures that occur over many different points in time. She is especially interested in large-scale lung cancer treatment and prevention studies and works on them and other cancer trials as a statistician for SWOG, a National Cancer Institute–funded cooperative that conducts studies at 650 institutions across the U.S.
Lung Cancer Committee, Southwest Oncology Group (SWOG)
Ph.D., Biostatistics, University of Washington, 2004
M.S., Biostatistics, University of Washington, 2000
B.S., Mathematics, University of Washington, 1997
Clinical trial design
Clinical trial design incorporating biomarkers